Mangoceuticals, Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $6.7M
- Price
- $0.389
- % Change (Daily % change from the live per-ticker quote feed.)
- +0.86%
- Volume
- 78.1K
About
Mangoceuticals, Inc. dedicates its operations to the creation, promotion, and distribution of a variety of health and wellness products and services specifically designed for men. These offerings are primarily delivered through a telemedicine platform. The company's product line includes treatments for erectile dysfunction, marketed under the 'Mango' brand. Consumers can purchase these items directly from its official online portal, mangorx.com. Established in 2021, Mangoceuticals, Inc. is headquartered in Dallas, Texas, and operates as an affiliate of Cohen Enterprises, Inc.
Quick stats
Shares outstanding17.2M
Computed float15.2M
Float / shares88.4%
Key info
SectorHealthcare
IndustryMedical - Healthcare Information Services
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001938046
AI Summary
AI-generated1/22
minorneutrallegal litigation
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC is investigating the proposed merger between Mangoceuticals and Nuclea Energy Inc. to determine if the board breached fiduciary duties.
The law firm is reviewing whether the transaction terms allow for superior offers or limit shareholder benefits.
Investors are encouraged to contact the firm regarding their rights, though no class has been certified at this time.